Fig. 2: Study design. | Leukemia

Fig. 2: Study design.

From: Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM)

Fig. 2

a First hydroxyurea (HU) treatment; b Hematocrit, other laboratory assessments, and phlebotomy measured ±14 days in the 6–9 month-post-index window; c Observations included: respiratory, heart, pulse, weight, height, body mass index, systolic blood pressure, diastolic blood pressure and demographics (gender, race, ethnicity, region, division, and age at index); d Adapted for real world evidence (RWE) with no hydroxyurea dosage applied.

Back to article page